<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01234389</url>
  </required_header>
  <id_info>
    <org_study_id>HN-0004</org_study_id>
    <nct_id>NCT01234389</nct_id>
  </id_info>
  <brief_title>Immediate Detection of Helicobacter Infection With a New Electrochemical System.</brief_title>
  <official_title>Immediate Detection of Helicobacter Infection With a New Electrochemical System</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Erlangen-Nürnberg Medical School</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Erlangen-Nürnberg Medical School</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Helicobacter pylori-infection (H. pylori) affects about fifty percent of the general
      population and is associated with peptic ulcer disease, non-cardia gastric adenocarcinoma and
      gastric lymphoma. Currently, diagnostic methods include breath tests, serology, stool antigen
      tests, histology or the Helicobacter urease test (HUT).

      The aim of our study is to access the clinical reliability of a new, electrochemical device
      for rapid H. pylori detection.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The newly developed electrochemical device for H. pylori detection consists of a working and
      reference electrode between which a biopsy sample is administered. Afterwards, acquired
      voltage-values could be analysed for characteristics typical for H. pylori infection
      (ammonia). According to Sydney classification, biopsies are taken from gastric antrum and
      corpus for electrochemical H. pylori detection, HUT and immunohistochemistry (IHC). HUT
      results are evaluated after 24 hours. Furthermore, every patient will receive 13C-urea breath
      test. IHC is designated as the gold standard of H. pylori diagnosis.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>October 2009</start_date>
  <completion_date type="Anticipated">January 2013</completion_date>
  <primary_completion_date type="Anticipated">January 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Effectiveness of the newly developed device in comparison to IHC, HUT and C13-urea breath test.</measure>
    <time_frame>Oktober 2009 - February 2011</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>H. Pylori Infection</condition>
  <arm_group>
    <arm_group_label>H. pylori positive patients</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>H. pylori negative patients</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Electrochemical H. pylori detection method</intervention_name>
    <description>Determination of H. pylori infection.</description>
    <arm_group_label>H. pylori positive patients</arm_group_label>
    <arm_group_label>H. pylori negative patients</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>IHC</intervention_name>
    <description>Determination of H. pylori infection.</description>
    <arm_group_label>H. pylori positive patients</arm_group_label>
    <arm_group_label>H. pylori negative patients</arm_group_label>
    <other_name>Determination of H. pylori infection.</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>C13-urea breath test</intervention_name>
    <description>Determination of H. pylori infection.</description>
    <arm_group_label>H. pylori positive patients</arm_group_label>
    <arm_group_label>H. pylori negative patients</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>HUT</intervention_name>
    <description>Determination of H. pylori infection.</description>
    <arm_group_label>H. pylori positive patients</arm_group_label>
    <arm_group_label>H. pylori negative patients</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Written informed consent

          -  Age 18-85 years

          -  Ability of subjects to understand character and individual consequences of clinical
             trial

          -  Subjects undergoing EGD

        Exclusion Criteria:

          -  Inability to provide written informed consent

          -  Severe Coagulopathy (Prothrombin time &lt; 50% of control, Partial thromboplastin time &gt;
             50 s)

          -  Pregnancy or breast feeding

          -  Active gastrointestinal bleeding

          -  Residing in institutions (e.g. prison)

          -  PPI intake

          -  antibiotic use, actual or within the last 4 weeks
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Markus F. Neurath, M.D., Ph.D.</last_name>
    <role>Study Director</role>
    <affiliation>University of Erlangen-Nürnberg</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Helmut Neumann, M.D., Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Erlangen-Nürnberg</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Markus F. Neurath, M.D., Ph.D.</last_name>
    <phone>4991318535204</phone>
    <email>markus.neurath@uk-erlangen.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Helmut Neumann, M.D., Ph.D.</last_name>
    <phone>4991318535204</phone>
    <email>helmut.neumann@uk-erlangen.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Erlangen-Nuremberg</name>
      <address>
        <city>Erlangen</city>
        <state>Bayern</state>
        <zip>91054</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Markus F. Neurath, M.D., Ph.D.</last_name>
      <phone>4991318535204</phone>
      <email>markus.neurath@uk-erlangen.de</email>
    </contact>
    <contact_backup>
      <last_name>Helmut Neumann, M.D., Ph.D.</last_name>
      <phone>4991318535204</phone>
      <email>helmut.neumann@uk-erlangen.de</email>
    </contact_backup>
    <investigator>
      <last_name>Helmut Neumann, M.D., Ph.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>January 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 2, 2010</study_first_submitted>
  <study_first_submitted_qc>November 2, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 4, 2010</study_first_posted>
  <last_update_submitted>January 23, 2013</last_update_submitted>
  <last_update_submitted_qc>January 23, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 24, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Erlangen-Nürnberg Medical School</investigator_affiliation>
    <investigator_full_name>Helmut Neumann</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infection</mesh_term>
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>Helicobacter Infections</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

